C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) C07H 21/00 (2006.01) C07K 14/47 (2006.01) C07K 14/82 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2262403
Disclosed are diagnostic techniques for the detection of human prostate cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate cancer compared to normal human prostate or benign prostatic hyperplasia.
L'invention concerne des techniques diagnostiques servant à détecter le cancer de la prostate chez l'homme. Elle concerne des sondes génétiques et des procédés permettant de contrôler la progression et le diagnostic du cancer de la prostate. Elle concerne particulièrement des sondes et des procédés d'évaluation de la présence d'espèces d'ARN exprimées différemment dans le cancer de la prostate par rapport à la prostate normale de l'homme ou à l'hyperplasie prostatique bénigne.
An Gang
O'hara S. Mark
Ralph David
Veltri Robert
Deeth Williams Wall Llp
Laboratory Corporation Of America Holdings
Urocor Inc.
LandOfFree
Biomarkers and targets for diagnosis, prognosis and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biomarkers and targets for diagnosis, prognosis and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers and targets for diagnosis, prognosis and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1757315